Corning Incorporated (NYSE:GLW) spotted trading -18.30% off 52-week high price. On the other end, the stock has been noted 11.16% away from the low price over the last 52-weeks. The stock changed 3.54% to recent value of $29.87. The stock transacted 4222054 shares during most recent day however it has an average volume of 3981.65K shares. The company has 782.91M of outstanding shares and 782.46M shares were floated in the market.
Corning Incorporated (NYSE:GLW) declared that two of its products – Corning® Med-X® Glass and Corning® Med-Gamma® Glass – are now registered as compliant with U.S. Food and Drug Administration (FDA) regulations. This compliance demonstrates Corning’s commitment to supporting public health, safety, and security through high-quality radiation-shielding glass.
“With this registration, Corning becomes the first radiation-shielding glass manufacturer on the market to provide its customers and their end-customers with full compliance and traceability adhering to FDA requirements,” said Pierre-Jean Baron, general manager, Corning Specialty Glass.
As per U.S. regulations, Corning registered with the FDA for Corning® Med-X® Glass and Corning® Med-Gamma® Glass under the classification of Radiology devices / Personnel protective shield. These two glass product categories are used as Class I medical devices as defined by the FDA.
Corning is a world leader in radiation shielding glass solutions for medical, nuclear, and industrial applications. In partnership with strategic distributors, equipment manufacturers, and shielding specialists around the world, Corning developed a comprehensive radiation shielding range with global production capabilities to complement its innovative glass solutions portfolio.
Its earnings per share (EPS) expected to touch remained 300.10% for this year while earning per share for the next 5-years is expected to reach at 13.95%. GLW has a gross margin of 39.70% and an operating margin of 15.50% while its profit margin remained 17.70% for the last 12 months.
According to the most recent quarter its current ratio was 2.1 that represents company’s ability to meet its current financial obligations. The price moved ahead of -0.54% from the mean of 20 days, -7.67% from mean of 50 days SMA and performed -8.38% from mean of 200 days price. Company’s performance for the week was 0.78%, -6.63% for month and YTD performance remained -1.13%.